Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study

BACKGROUND: Thrombosis is a frequent and severe complication in patients with coronavirus disease 2019 (COVID‐19) admitted to the intensive care unit (ICU). Lupus anticoagulant (LA) is a strong acquired risk factor for thrombosis in various diseases and is frequently observed in patients with COVID‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Noordermeer, Tessa, Schutgens, Roger E. G., Visser, Chantal, Rademaker, Emma, de Maat, Moniek P. M., Jansen, A. J. Gerard, Limper, Maarten, Cremer, Olaf L., Kruip, Marieke J. H. A., Endeman, Henrik, Maas, Coen, de Laat, Bas, Urbanus, Rolf T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481876/
https://www.ncbi.nlm.nih.gov/pubmed/36178455
http://dx.doi.org/10.1002/rth2.12809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481876/
https://www.ncbi.nlm.nih.gov/pubmed/36178455
http://dx.doi.org/10.1002/rth2.12809

Ejemplares similares